[go: up one dir, main page]

EA201070966A1 - Фолаты, композиции и применение указанных композиций - Google Patents

Фолаты, композиции и применение указанных композиций

Info

Publication number
EA201070966A1
EA201070966A1 EA201070966A EA201070966A EA201070966A1 EA 201070966 A1 EA201070966 A1 EA 201070966A1 EA 201070966 A EA201070966 A EA 201070966A EA 201070966 A EA201070966 A EA 201070966A EA 201070966 A1 EA201070966 A1 EA 201070966A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
folates
applications
indicated
well
Prior art date
Application number
EA201070966A
Other languages
English (en)
Other versions
EA017742B1 (ru
Inventor
Эрманно Валоти
Давиде Бьянки
Марко Валетти
Original Assignee
Ньосис С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ньосис С.П.А. filed Critical Ньосис С.П.А.
Publication of EA201070966A1 publication Critical patent/EA201070966A1/ru
Publication of EA017742B1 publication Critical patent/EA017742B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение касается фолатов, композиций и применения указанных композиций; в частности, настоящее изобретение описывает кристаллические и аморфные соединения, являющиеся замещенными или незамещенными фолатами, или восстановленными фолатами либо природными или неприродными изомерами по меньшей мере одного органического основания, а также композиции и применение указанных композиций. Соединения по изобретению обладают длительной стабильностью, а также особенно высокой водорастворимостью.
EA201070966A 2008-02-20 2008-02-20 Фолаты, композиции и применение указанных композиций EA017742B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2008/052037 WO2009103334A1 (en) 2008-02-20 2008-02-20 Folates, compositions and uses thereof

Publications (2)

Publication Number Publication Date
EA201070966A1 true EA201070966A1 (ru) 2011-02-28
EA017742B1 EA017742B1 (ru) 2013-02-28

Family

ID=40299393

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070966A EA017742B1 (ru) 2008-02-20 2008-02-20 Фолаты, композиции и применение указанных композиций

Country Status (22)

Country Link
EP (1) EP2245032B1 (ru)
JP (1) JP5856372B2 (ru)
KR (1) KR101512624B1 (ru)
CN (1) CN101970439B (ru)
AU (1) AU2008351242B2 (ru)
BR (1) BRPI0822337B8 (ru)
CA (1) CA2712714C (ru)
CY (1) CY1116343T1 (ru)
DK (1) DK2245032T3 (ru)
EA (1) EA017742B1 (ru)
ES (1) ES2538480T3 (ru)
HR (1) HRP20150674T1 (ru)
HU (1) HUE025450T2 (ru)
IL (1) IL207164A (ru)
MX (1) MX2010009075A (ru)
NZ (1) NZ586959A (ru)
PL (1) PL2245032T3 (ru)
PT (1) PT2245032E (ru)
SI (1) SI2245032T1 (ru)
UA (1) UA103310C2 (ru)
WO (1) WO2009103334A1 (ru)
ZA (1) ZA201005278B (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103450202B (zh) * 2012-06-04 2015-07-01 南京莱因医药科技有限公司 L-5-甲基四氢叶酸与有机碱加成盐的方法
CN103664945B (zh) * 2012-09-07 2016-01-20 南京莱因医药科技有限公司 L-5-甲基四氢叶酸氨基酸盐的制备方法
JP2015024965A (ja) * 2013-07-24 2015-02-05 株式会社えがお グルコサミン有機酸抱合物およびその製造方法
MX387797B (es) * 2014-05-30 2025-03-19 Shaklee Corp Extracto de semilla de uva chardonnay.
US10398697B2 (en) 2014-09-04 2019-09-03 Lianyungang Jinkang Hexin Pharmaceutical Co., Ltd. Solid solution comprising (6S)-5-methyl tetrahydrofolic acid or salt thereof, and preparation and use thereof
CN106901379B (zh) * 2017-03-11 2021-08-13 深圳奥萨制药有限公司 一种辅助预防心血管疾病的维生素保健食品
CN106974292B (zh) * 2017-03-22 2021-02-26 深圳奥萨制药有限公司 一种由维生素d、e及叶酸组成的维生素组合物保健食品
DK3609894T3 (da) 2017-03-31 2024-09-09 Merck Patent Gmbh Krystallinsk natriumsalt af 5-methyl-(6s)-tetrahydrofolsyre
EP3609895B1 (en) 2017-03-31 2024-10-16 Merck Patent GmbH Crystalline sodium salt of 5-methyl-(6s)-tetrahydrofolic acid
EP3461826A1 (en) * 2017-09-29 2019-04-03 Aprofol AG Multifunctional folate salts
EP3586849A1 (en) * 2018-06-29 2020-01-01 Aprofol AG Folate preparations
AU2019297309B2 (en) 2018-07-06 2024-08-29 Merck Patent Gmbh Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester
EP3818048B1 (en) * 2018-07-06 2023-09-20 Merck Patent GmbH Crystalline salt comprising 5-methyl-(6s)-tetrahydrofolic acid and 4-(2-hydroxyethyl)-morpholine
EP3646873A1 (en) 2018-10-31 2020-05-06 Aprofol AG Folate salts
CN110313568A (zh) * 2018-12-24 2019-10-11 中健(广州)生物医药研究院有限公司 一种叶酸增强益生菌型固体饮料及其制备方法
CN110302090A (zh) * 2018-12-24 2019-10-08 中健(广州)生物医药研究院有限公司 L-5-甲基四氢叶酸氨基葡萄糖盐在化妆品中的应用
CN109748920A (zh) * 2018-12-24 2019-05-14 中健(广州)生物医药研究院有限公司 一种l-5-甲基四氢叶酸氨基葡萄糖盐及其合成方法
CN110974917A (zh) * 2019-11-25 2020-04-10 垒途智能教科技术研究院江苏有限公司 一种具有辅助防治儿童、青少年心理抑郁的作用的复合制剂
CN115040489B (zh) * 2022-08-17 2022-10-25 北京罗诺强施医药技术研发中心有限公司 具有优良一致性的稳定药物组合物及其制法
EP4501315A1 (en) 2023-08-04 2025-02-05 Lesaffre et Compagnie Liquid formulations of folates
WO2025132557A1 (en) 2023-12-20 2025-06-26 Lesaffre Et Compagnie Solid formulations of tetrahydrofolates

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2137186A1 (en) * 1971-05-14 1972-12-29 Mauvernay Centre Europ Folic acid salts - used as neuro-stimulants and for dynamising muscular function
JPS57123140A (en) * 1981-01-23 1982-07-31 Sankyo Co Ltd Ml-236b carboxylic acid amine salt and remedy for hyperlipemia containing said salt as active component
IT1195288B (it) * 1981-11-05 1988-10-12 Zambeletti Spa L Composizione farmaceutica per la terapia di calcolosi renale infetta
CA2021042A1 (en) * 1989-07-21 1991-01-22 Fabrizio Marazza Salts of n ,n -methylene-5,6,7,8-tetrahydrofolic acid
IT1245889B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.
CH689831A5 (de) * 1995-11-07 1999-12-15 Eprova Ag Stabile kristalline Tetrahydrofolsaeure-Salze.
CH693905A5 (de) * 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
WO2005112667A1 (ja) * 2004-05-20 2005-12-01 Takashi Omori 健康食品
JP2006131611A (ja) * 2004-10-07 2006-05-25 Otsuka Pharmaceut Factory Inc 骨代謝・たんぱく質代謝改善用栄養組成物

Also Published As

Publication number Publication date
KR101512624B1 (ko) 2015-04-16
BRPI0822337B8 (pt) 2021-05-25
IL207164A0 (en) 2010-12-30
ES2538480T3 (es) 2015-06-22
CA2712714A1 (en) 2009-08-27
WO2009103334A1 (en) 2009-08-27
PL2245032T3 (pl) 2015-08-31
HRP20150674T1 (hr) 2015-07-31
CN101970439B (zh) 2014-11-12
MX2010009075A (es) 2010-11-26
PT2245032E (pt) 2015-07-21
BRPI0822337A2 (pt) 2015-06-16
JP2011512366A (ja) 2011-04-21
AU2008351242A1 (en) 2009-08-27
ZA201005278B (en) 2011-09-28
CN101970439A (zh) 2011-02-09
EA017742B1 (ru) 2013-02-28
BRPI0822337B1 (pt) 2019-02-12
SI2245032T1 (sl) 2015-08-31
NZ586959A (en) 2012-04-27
JP5856372B2 (ja) 2016-02-09
KR20110011602A (ko) 2011-02-08
UA103310C2 (en) 2013-10-10
HUE025450T2 (en) 2016-04-28
EP2245032A1 (en) 2010-11-03
AU2008351242A2 (en) 2010-09-09
IL207164A (en) 2015-01-29
EP2245032B1 (en) 2015-03-25
CY1116343T1 (el) 2017-02-08
AU2008351242B2 (en) 2012-12-20
CA2712714C (en) 2015-05-12
DK2245032T3 (da) 2015-06-22

Similar Documents

Publication Publication Date Title
EA201070966A1 (ru) Фолаты, композиции и применение указанных композиций
CY1119515T1 (el) Οξαζολο υποκατεστημενα ινδαζολια ως αναστολεις ρι3-κινασης
CY1119245T1 (el) Φαρμακευτικη συνθεση καρβετοκινης
EA201270254A1 (ru) Производные 5-фторпиримидинона
EA201070912A1 (ru) Производные оксима в качестве ингибиторов hsp90
EA201270339A1 (ru) Замещенные производные ксантина
EA201270257A1 (ru) Производные n1-сульфонил-5-фторпиримидинона
EA201500530A1 (ru) 1,2,5-оксадиазолы в качестве ингибиторов индоламин-2,3-диоксигеназы
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
EA201101699A1 (ru) Синергетические фунгицидные смеси
EA201490132A1 (ru) Противовирусные соединения
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
ECSP11010880A (es) Compuestos orgánicos
PE20120495A1 (es) 3-ciclopentilamino-2,2-difluor-propanoato de etilo como intermediario en la preparacion de pirimidodiazepinas
EA201000950A1 (ru) Азолилметилоксираны, их применение, а также содержащие их средства
PA8676401A1 (es) Metodos para purificar tigeciclina
CO6341581A2 (es) Derivados de heteroarilo como inhibidores de dgat1
ECSP14004812A (es) Triazolopiridinas sustituidas
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
PA8779101A1 (es) "compuestos tricíclicos como inhibidores de metaloproteinasas matriciales"
ATE554066T1 (de) Entzündungshemmende substituierte cyclobutendionverbindungen
EA201490846A1 (ru) Новые производные арилхинолина
EA201171211A1 (ru) Производные оксадиазола
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM